SCHEMBL7583708

SCHEMBL7583708

Cc1ccc(C(=O)Nc2ccc(S(=O)(=O)n3cc(C[C@@H](N)C(=O)NO)c4ccccc43)cc2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 7/20 0.51
IDE P14735 1/20 0.51
CYP19A1 P11511 1/20 0.48
ALK Q9UM73 1/20 0.46
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
MAPK1 P28482 1/20 0.45
PDE4A P27815 1/20 0.44
PDE4B Q07343 1/20 0.44
PDE4C Q08493 1/20 0.44
PDE4D Q08499 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2C9 P11712 1/20 0.44
HDAC1 Q13547 1/20 0.44
HDAC2 Q92769 1/20 0.44
HDAC6 Q9UBN7 1/20 0.44
MMP9 P14780 1/20 0.44
ALOX5 P09917 1/20 0.43
PTGS2 P35354 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7588756 0.88 IDE (0.47) HTR6IDECYP19A1ALKMEN1
SCHEMBL838015 0.80 HTR6 (0.64) HTR6IDECYP19A1ALKALOX5
SCHEMBL838017 0.80 HTR6 (0.64) HTR6IDECYP19A1ALKALOX5
SCHEMBL4932964 0.73 NPC1 (0.58) MEN1KMT2ACYP2C9HDAC1HDAC6
SCHEMBL4932973 0.73 NPC1 (0.58) MEN1KMT2ACYP2C9HDAC1HDAC6
SCHEMBL6545705 0.72 IDE (0.55) HTR6IDECYP19A1ALKALOX5
SCHEMBL946516 0.72 HTR6 (0.74) HTR6CYP19A1ALKALOX5PTGS2
SCHEMBL29169612 0.71 HTR6 (0.64) HTR6IDECYP19A1ALKALOX5
SCHEMBL850128 0.71 ALOX5 (0.62) HTR6CYP19A1ALKALOX5PTGS2
SCHEMBL3639382 0.70 HTR6 (0.53) HTR6CYP19A1ALKPDE4APDE4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0757984-B1 Hydroxamic acid derivatives useful for inhibiting gelatinase ONO PHARMACEUTICAL CO (JP) 2002-10-30 EP claimed
US-6022893-A PREVENTION AND TREATMENT OF DISEASES INDUCED BY OVEREXPRESSION OR EXCESS ACTIVATION OF GELATINASES ONO PHARMACEUTICAL CO., LTD. (JP) 2000-02-08 US claimed
EP-0757984-A1 Hydroxamic acid derivatives useful for inhibiting gelatinase ONO PHARMACEUTICAL CO., LTD. (JP) 1997-02-12 EP claimed
EP-0757984-B1 Hydroxamic acid derivatives useful for inhibiting gelatinase ONO PHARMACEUTICAL CO (JP) 2002-10-30 EP disclosed
US-6022893-A PREVENTION AND TREATMENT OF DISEASES INDUCED BY OVEREXPRESSION OR EXCESS ACTIVATION OF GELATINASES ONO PHARMACEUTICAL CO., LTD. (JP) 2000-02-08 US disclosed
EP-0757984-A1 Hydroxamic acid derivatives useful for inhibiting gelatinase ONO PHARMACEUTICAL CO., LTD. (JP) 1997-02-12 EP disclosed